Bing T. He
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Multi-Technique Integration Identifies O-GlcNAc Transferase in Fibroblast-Like Synoviocytes as a Therapeutic Target for Rheumatoid Arthritis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2026
Investigating the causal relationship of lipid metabolism in polycystic ovary syndrome: a Mendelian randomization study on the regulatory role of 3-Hydroxybutyrate in gene expression.
Journal: Frontiers in medicine
Published: January 10, 2026
Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B viruses.
Journal: Cell host & microbe
Published: August 27, 2025
Gut microbiota dysbiosis in polycystic ovary syndrome: focus on diet, probiotics, and traditional Chinese medicine.
Journal: Frontiers in microbiology
Published: July 07, 2025
De novo design of epitope-specific antibodies via a structure-driven computational workflow.
Journal: Nature communications
Published: June 05, 2025
Functional protein design and enhancement with ontology reinforcement iteration.
Journal: Nature communications
Published: May 21, 2025
A pan-disease and population-level single-cell TCRαβ repertoire reference.
Journal: Cell discovery
Published: March 11, 2025
Application value of surface respiratory muscle electromyography and its ratio to tidal volume in the assessment of airway hyperresponsiveness in bronchial asthma patients
Journal: Zhonghua yi xue za zhi
Published: January 07, 2025
Causal relationship between immune cells, metabolites and polycystic ovary syndrome identified by Mendelian randomization and mediation analyses.
Journal: Immunology and cell biology
Published: September 02, 2024
De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model.
Journal: Nature communications
Published: November 14, 2023
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine.
Journal: Vaccine
Published: June 22, 2023
Last Updated: 09/26/2026